Insights On Quality Assurance

1. Reasons To Bring Digital Solutions To Your Organization 6/22/2024

   This presentation explores how many organizations have not fully utilized digital and analytics tools, leading to inefficiencies in data management and delays in delivering therapeutics to market.

2. Insights And Strategies For GMP Manufacturing Of RNA-Lipid Nanoparticles 4/25/2024

   The emergence of RNA-encapsulated-lipid nanoparticles has introduced a seismic shift in biopharma innovation. But how will the industry adapt to diversifying applications and scales going forward?

3. A Roadmap For Implementing Analytical QbD 7/5/2024

   Discover how an analytical QbD approach ensures that analytical methods are not only effective but resilient to variations, ultimately enhancing the reliability and accuracy of the data generated.

4. The Write Side Of AI: Augmenting Capabilities, Not Replacing Them 3/1/2024

   AI applications in medical writing are in their infancy, and the technology suffers several shortcomings including plagiarism, copyright infringement, and misinformation dissemination.

5. Design Testing Strategies To Develop A Drug-Device Combination Product 8/27/2024

   Leveraging the expertise and experience of a trusted partner can reduce risk and accelerate the time to market for drug-device combination products by creating an optimal Validation Master Plan.

6. Optimizing Process Loads For VHP Decontamination 2/20/2024

   Explore how CAI helped a company rescue a failing CQV project and create more efficient Vaporized Hydrogen Peroxide Material Air Lock (VHP MAL) Loads to enhance operational efficiency.

7. Monitoring And Determining The Cause Of Antibody Discoloration Using cIEF And EAD 9/21/2023

   View a study which provides additional insight into the factors that govern the discoloration of protein therapeutics and the role of AGEs in color change.

8. Pressure Testing Your Readiness To Ensure GMP Batch #1 Success 5/28/2024

   Watch as an expert from an industry-leading CDMO provides insights into the crucial factors, challenges, and tech transfer methods needed to achieve right-first-time readiness and success.

9. US GMP (21 CFR 820) Manufactured Oligos For Preclinical Research 10/18/2023

   Learn why Custom cGMP Oligos should be considered to ensure oligo products meet the strict standards of MDx, LDTs, and preclinical research.

10. ICH Guidelines: Challenges And Solutions For Pharma Manufacturers 10/8/2024

    Take the next step in enhancing your pharmaceutical manufacturing processes by investing in a robust quality management system (QMS) designed for ICH compliance and operational excellence.